NephroGenex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
NephroGenex, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $4.28 per share as of 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2016-03-29
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $4.28.
- 2015-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $4.46.
- 2015-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $4.49.
- 2015-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $4.16.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2015-12-31 | $4.28 10-K · filed 2016-03-29 | |
| 2015-09-30 | $4.46 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $4.49 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $4.16 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $4.19 10-K · filed 2016-03-29 | |
| 2014-09-30 | $4.03 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $3.98 10-Q · filed 2014-08-12 | |
| 2013-12-31 | $1.18 10-K · filed 2016-03-29 | $1.17 10-Q · filed 2014-08-12 |
| 2012-12-31 | $1.11 10-K · filed 2015-03-24 |